ClinicalTrials.govpublic full text
Bortezomib in Late Antibody-mediated Kidney Transplant Rejection
late rejection of renal transplant, antibody-mediated rejection, kidney transplantation, antibody formation, graft rejection, proteasome inhibitors, randomized controlled trial, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 907491
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.